2003 related articles for article (PubMed ID: 15630071)
1. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
[TBL] [Abstract][Full Text] [Related]
2. Patient characteristics and treatment implications of marijuana abuse among bipolar alcoholics: results from a double blind, placebo-controlled study.
Salloum IM; Cornelius JR; Douaihy A; Kirisci L; Daley DC; Kelly TM
Addict Behav; 2005 Oct; 30(9):1702-8. PubMed ID: 16098680
[TBL] [Abstract][Full Text] [Related]
3. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
4. Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.
McElroy SL; Bowden CL; Collins MA; Wozniak PJ; Keck PE; Calabrese JR
J Affect Disord; 2008 Apr; 107(1-3):127-33. PubMed ID: 17888516
[TBL] [Abstract][Full Text] [Related]
5. Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study.
Salloum IM; Douaihy A; Cornelius JR; Kirisci L; Kelly TM; Hayes J
Addict Behav; 2007 Feb; 32(2):410-5. PubMed ID: 16814474
[TBL] [Abstract][Full Text] [Related]
6. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study.
Brady KT; Sonne SC; Anton R; Ballenger JC
J Clin Psychiatry; 1995 Mar; 56(3):118-21. PubMed ID: 7883730
[TBL] [Abstract][Full Text] [Related]
7. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
8. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
Bowden CL; Vieta E; Ice KS; Schwartz JH; Wang PP; Versavel M
J Clin Psychiatry; 2010 Feb; 71(2):130-7. PubMed ID: 20122373
[TBL] [Abstract][Full Text] [Related]
9. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
[TBL] [Abstract][Full Text] [Related]
10. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence.
Simpson TL; Saxon AJ; Meredith CW; Malte CA; McBride B; Ferguson LC; Gross CA; Hart KL; Raskind M
Alcohol Clin Exp Res; 2009 Feb; 33(2):255-63. PubMed ID: 18945226
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
12. Divalproex in the treatment of bipolar depression: a placebo-controlled study.
Davis LL; Bartolucci A; Petty F
J Affect Disord; 2005 Apr; 85(3):259-66. PubMed ID: 15780695
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
14. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
[TBL] [Abstract][Full Text] [Related]
15. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.
Wilens TE; Adler LA; Weiss MD; Michelson D; Ramsey JL; Moore RJ; Renard D; Brady KT; Trzepacz PT; Schuh LM; Ahrbecker LM; Levine LR;
Drug Alcohol Depend; 2008 Jul; 96(1-2):145-54. PubMed ID: 18403134
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.
Martinotti G; Andreoli S; Di Nicola M; Di Giannantonio M; Sarchiapone M; Janiri L
Hum Psychopharmacol; 2008 Jul; 23(5):417-24. PubMed ID: 18425995
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen.
Yildiz A; Guleryuz S; Ankerst DP; Ongür D; Renshaw PF
Arch Gen Psychiatry; 2008 Mar; 65(3):255-63. PubMed ID: 18316672
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
Keck PE; McElroy SL
J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
